Blackstone Inc Essa Pharma Inc. Transaction History

Blackstone Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$6.18 - $14.44 $8.03 Million - $18.8 Million	-1,300,000 Reduced 39.36%	2,003,103 $12.4 Million
Q2 2021 Aug 16, 2021	SELL	$24.17 - $34.28 $6.52 Million - $9.25 Million	-269,950 Reduced 7.56%	3,303,103 $94.4 Million
Q3 2020 Nov 16, 2020	BUY	$6.0 - $7.79 $1.2 Million - $1.56 Million	200,000 Added 5.93%	3,573,053 $24.7 Million
Q3 2019 Nov 14, 2019	BUY	$1.46 - $3.37 $2.49 Million - $5.74 Million	1,704,493 Added 102.15%	3,373,053 $11.4 Million
Q4 2018 Feb 14, 2019	BUY	$1.9 - $4.02 $3.17 Million - $6.71 Million	1,668,560 New	1,668,560 $3.5 Million

35.1M

15.8K

21K

Ticker EPIX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 44,073,100
Market Cap $78.9M
Description
ESSA Pharma Inc., a clinical stage pharmaceutical company, focuses on developing novel and proprietary therapies for the treatment of prostate cancer. It develops EPI-7386, an oral candidate that is in a Phase I clinical study for the treatment of patients with metastatic castration-resistant prostate cancer. The company has collaboration agreem...

Get notified when there are updates to the investment portfolio of Blackstone Inc, based on Form 13F filings with the SEC.

Stay updated on Blackstone Inc with notifications on news.